title: Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells.
abstract: Macrolide antibiotics modulate the production of proinflammatory cytokines in vivo and in vitro. Transcription of the genes for these proinflammatory cytokines is regulated by nuclear factor kappaB (NF-kappaB). We examined whether or not clarithromycin inhibits the activation of NF-kappaB induced by tumor necrosis factor alpha (TNF-alpha) or staphylococcal enterotoxin A (SEA) in human monocytic U-937 cells, a T-cell line (Jurkat), a pulmonary epithelial cell line (A549), and peripheral blood mononuclear cells (PBMC). Flow cytometry revealed that clarithromycin suppresses NF-kappaB activation induced by TNF-alpha in U-937 and Jurkat cells in a concentration-related manner. Western blot analysis also demonstrated that clarithromycin inhibits NF-kappaB activation induced by TNF-alpha in U-937, Jurkat, and A549 cells and PBMC and by SEA in PBMC. Western blot analysis of cytoplasmic extracts of A549 cells revealed that this inhibition is not linked to preservation of expression of the IkappaBalpha protein. The chloramphenicol acetyltransferase assay indicated that NF-kappaB-dependent reporter gene expression is suppressed in U-937 cells pretreated with clarithromycin. These findings are consistent with the idea that clarithromycin suppresses the production of proinflammatory cytokines via inhibition of NF-kappaB activation.
authors: Department of Pediatrics, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan. ichiyama@po.cc.yamaguchi-u.ac.jp
authors: T
authors: T
authors: Ichiyama
authors: M
authors: M
authors: Nishikawa
authors: T
authors: T
authors: Yoshitomi
authors: S
authors: S
authors: Hasegawa
authors: T
authors: T
authors: Matsubara
authors: T
authors: T
authors: Hayashi
authors: S
authors: S
authors: Furukawa
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D015153:Blotting, Western; D002460:Cell Line; D002467:Cell Nucleus / Q000187:drug effects / Q000201:enzymology; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics / Q000378:metabolism; D017291:Clarithromycin / Q000494:pharmacology*; D004847:Epithelial Cells / Q000187:drug effects; D005434:Flow Cytometry; D006801:Humans; D019169:Jurkat Cells; D008168:Lung / Q000166:cytology* / Q000187:drug effects; D009000:Monocytes / Q000187:drug effects*; D016328:NF-kappa B / Q000187:drug effects*; D010957:Plasmids / Q000235:genetics; D013205:Staphylococcal Protein A / Q000494:pharmacology; D014162:Transfection; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D016328:NF-kappa B; D013205:Staphylococcal Protein A; D014409:Tumor Necrosis Factor-alpha; D015500:Chloramphenicol O-Acetyltransferase; D017291:Clarithromycin